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Free radicals are identified as molecules having one
or more unpaired electrons in their outer orbits, the
name radicals means unstable. Free radicals gain
the stability by attracting electrons from neighbor-
ing molecules as proteins, enzymes, lipids or amino
acids (Abd Ellah, 2013a). They are highly reactive
substances produced continuously during meta-
bolic processes and participating mainly in physi-
ological events such as immune response,
metabolism of unsaturated fatty acids, and inflam-
matory reactions. The most important free radicals
include superoxide anion (O2.−), hydroxyl radical
(.OH), and hypochlorous acid (Stohs, 1995; Abd
Ellah, 2010). Generally, sources of free radicals are
oxidative phosphorylation through the mitochon-
drial electron transport chain, cytochrome P450 en-
zymes, oxidase enzymes like NADPH oxidases.
Furthermore, capillaries of the glomerular and tu-
bular cells, circulating leucocytes and platelets rep-
resent important sources for production of free
radicals (Wardle, 2005). It has long been recog-
nized that reactive oxygen species (ROS) are harm-
ful for cells, mainly because they leads to structural
and functional impairments of lipids, proteins, and
nucleic acids (Freeman and Crapo, 1982; Mantle
and Preedy, 1999).
Role of antioxidants in renal diseases
The cells contain a variety of antioxidants mecha-
nisms that play a central role in the protection
against ROS (Pár and Jávor, 1984; Halliwell,
1991). The antioxidant system is classified into two
major parts: the first one is the antioxidant en-
zymes, which include superoxide dismutase
(SOD), catalase, glutathione peroxidase (GSH-Px),
and ancillary enzymes (glutathione reductase (GR),
glutathione S-transferase, and glucose 6-phosphate
dehydrogenase. The second class of antioxidants is
vitamins including alpha-tocopherol, ascorbate,
and beta-carotene (Halliwell, 1994; Abd Ellah,
2010). Both the enzymatic and non-enzymatic an-
tioxidants become overwhelmed during oxidative
stress, due to excessive generation of ROS. 
Chain breaking antioxidants include vitamin E,
C and beta-carotene represent the second line of
defense that protects different tissues against ox-
idative stress. Vitamin E is located both intracellu-
larly and extracellularly; one of its functions is to
improve the oxidative status and to remove lipid
peroxy radicals formed during the process of in-
creased oxidative stress (Cristol et al., 1997). On
the other hand, vitamin C has sparing effect on vi-
tamin E, as it helps recycling of α-tocopherol from
its oxidized form to native form. The role of ascor-
bic acid and vitamin E in relieve of renal diseases
has been established by many studies; decreased of
ascorbic acid and vitamin E levels in sera of uremic
patients were reported by Giardini et al. (1984) and
Frei et al. (1989). Also, decreased oxidative stress
and relieve of renal cell injury were observed after
supplementation of vitamin C (Frei et al., 1989).
Supplementation of vitamin E suppresses oxidative
stress and retards kidney failure (Gorgum et al.,
1999). Furthermore, dietary treatment with vitamin
E diminished renal functional and structural
changes in experimental glomerulopathy in rats
(Trachtman et al., 1996).  
Oxidative stress and renal diseases
Cellular release of free radicals is controlled by the
defense mechanism in the form of antioxidants.
Over production of free radicals and/or decrease
the antioxidants defence mechanisms are the main
predisposing cause for the occurrence of oxidative
stress (Abd Ellah, 2013b). Furthermore, neu-
trophils get attracted to the site of inflammation un-
dergo a ‘respiratory burst’ resulting in excessive
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production of oxygen free radicals (Paller and Hed-
lund, 1988). In many experimental studies, the par-
ticipation of reactive oxygen species (ROS) in
glomerular damage was confirmed by measuring
the products of oxidant injury and antioxidants lev-
els in renal tissue and urine (Wojcicka and Bel-
towski 2001). Many toxic chemicals induce
nephrotoxicity through the generation of ROS as
suggested by Somani et al. (2000). Also, tissue
deposition of immune complexes can induce an
acute inflammatory response resulting in tissue in-
jury. Many research studies had been reported that
oxidative stress mediates a wide range of renal in-
juries, which ranging from acute renal failure
(Paller et al., 1998; Baliga et al., 1999; Shah,
2001), rhabdomyolysis (Vanholder et al., 2000),
obstructive nephropathy (Klahr, 2001), hyperlipi-
demia (Wanner et al., 1997; Sakatsume et al.,
2001) and glomerular damage (Kitamura and
Ishikawa, 1999) to chronic renal failure (Handel-
man et al., 2001). Studies in models of acute renal
failure (ARF) have generated evidence that ROS
production occurs during ischemia/reperfusion
(Greene and Paller 1991).
Reactive oxygen species are involved in the
pathogenesis of toxic, ischemic, immunologically
mediated renal injury (Baude and Ardaillou 1993)
and chronic renal failure (CRF). The increased pro-
duction of ROS in CRF may be related to meta-
bolic consequences of the uremia such as decreased
production of NADPH (Yawata and Jacob, 1975)
and GSH-Px activity (Schiavon et al., 1994) and
lowered vitamin E level (Yalcin et al., 1989). The
potential consequences of increased generation of
ROS in CRF are accelerated atherosclerosis (Green
et al., 1983) and increased RBCs rigidity, which
may shorten erythrocyte life span and contribute to
renal anemia (Kikuchi et al., 1982 and (Delmas-
Beauvieux et al., 1995). Some studies considered
oxidative stress in CRF as an important source of
patient morbidity and mortality, through their in-
volvement in the pathogenesis of malnutrition
(Galle, 2001, Maggi et al., 1994; Galle et al.,
2003), anaemia (Taccone-Gallucci et al., 1999),
and increased risk of cancerogenesis (Vamvakas et
al., 1998).
Studying the status of the oxidative stress in an-
imals is lacking. In one study, vitamin antioxidants
such as vitamin E, C and β-carotene levels were
measured in blood of camels suffered from cystitis
(Abd Ellah et al., 2012), the authors reported de-
crease serum vitamin C level in camels with
chronic cystitis compared with those suffered from
acute cystitis, and decreases in serum α-tocopherol
and  β-carotene  levels  in  both  acute  and chronic
cystitis affected camels, which indicated the exces-
sive production of free radicals that assimilate
available vitamin C (Tappe, 1968).
Dogs with renal azotaemia were reported to
have a higher intra-erythrocytic CAT activity. How-
ever, glutathione content and plasma malondialde-
hyde (MDA) level were unaltered (Buranakarl et
al., 2009).The antioxidant vitamin E ameliorates
the effects of glomerular disease. Dietary treatment
with the antioxidant vitamin E attenuated renal
functional and structural changes in experimental
glomerulopathy (Trachtman et al., 1996). It was
demonstrated that and vitamins A, C, and E have a
protective role against LPO of erythrocytes in pa-
tients with CRF. 
Auto-transplantation method in canine is a good
model to evaluate the problems of ischemia– reper-
fusion (I/R) injury. The reperfusion injury caused
by oxidative stress is relieved by antioxidant sup-
plementation. In a renal transplantation model,
ascorbic acid alone was reported to play a role in
attenuating I/R injury and assisted in the recovery
of the renal function (Lee et al., 2006). 
Lipid peroxidation in renal diseases
There are some predisposing factors for the forma-
tion of lipid peroxidation in tissues. One of these
factors is the increased destruction of cells espe-
cially in renal ischemia, which associated with
overproduction of free radicals. Another important
factor is the decrease of antioxidants, which be-
come evident with the progress of the diseases. The
presence of the two factors or one of them may re-
sult in lipid peroxidation. In addition, cell mem-
brane contains high amount of polyunsaturated
fatty acids, which combine with free radicals to
form lipid peroxide derivatives. The production of
free radicals may cause the progress of the renal in-
jury to acute renal failure, especially after is-
chaemic renal injury as reported by Mark et al.
(1984); Ratych and Bulkley (1986); Greene and
Paller (1991) and Rao Srinivasa et al. (1996). In
patients with chronic renal failure, increased pro-
duction of free radicals had been reflected by in-
creased peroxidation of erythrocyte membranes
(Morosetti et al., 1987; Ginevri et al., 1989; To-
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borek et al., 1992).
Lipid peroxidation had been reported in patients
with acute renal failure, which occurred during my-
ohemoglobinuria (Abheri et al., 2010) that was ex-
plained by the increased iron in the renal tissues,
which react with free radicals and predispose to the
formation of toxic radicals.
Conclusion
The present review threw the light on previous re-
searches that aimed to study the response of the ox-
idant and antioxidants balance to different diseases
of the urinary system. Studying the oxidative stress
in diseases of the urinary system in animals are
lacking compared with similar researches in
human. Further studies are required to elucidate the
oxidative status in urinary system diseases in rela-
tion to the productive and reproductive capacity of
different animal species.
References
Abd Ellah, M.R., 2010. Involvement of free radi-
cals in animal diseases. Comparative Clinical
Pathology 19, 615–619.
Abd Ellah, M.R., 2013a. Involvement of free rad-
icals in parasitic infestations. Journal of Ap-
plied Animal Research
DOI:10.1080/09712119.2012.739093.
Abd Ellah, M.R., 2013b. Role of free radicals and
antioxidants in mastitis. Journal of Advanced
Veterinary Research 3: 1-7.
Abd Ellah, M.R., Gaber, F.Kh., Neveen, A.E.,
2012. Serum lipoproteins, antioxidants and
urine biochemical constituents in camel cys-
titis. Comparative Clinical Pathology 21,
515-519.
Abheri, D.S., Anisur, R.M., Ghosh, A.K., 2010.
Free Radicals and Their Role in Different
Clinical Conditions: An Overview. Interna-
tional Journal of Pharmacological Sciences
and Research 1, 185-192.
Baliga, P., Ueda, N., Walker, P.D., Shah, S.V.,
1999. Oxidant mechanism in toxic acute
renal failure. Drug Metabolism Reviews 31,
971–997.
Baude, L., Ardaillou, R., 1993. Involvement of re-
active oxygen species in kidney damage.
British Medical Bulletin 49, 621–629
Buranakarl, C., Trisiriroj, M., Pondeenana, S.,
Tungjitpeanpong, T., Jarutakanon, P., Pen-
chome, R., 2009. Relationships between ox-
idative stress markers and red blood cell
characteristics in renalnazotemic dogs. Re-
search in Veterinary Science 86, 309–313. 
Cristol, J.P., Bosc, J.Y., Badiou, S., Leblanc, M.,
Lorrho R., 1997. Erythropoitein and oxida-
tive stress in haemodialysis: Beneficial ef-
fects of vitamin E supplementation.
Nephrology Dialysis Transplantation 12,
2312-2317. 
Delmas-Beauvieux, M.C., Peuchant, E., Dumon,
M.F., Receveur, M.C., Le Bras, M., Clerc,
M., 1995. Relationship between red blood
cell antioxidant enzymatic system status and
lipoperoxidation during the acute phase of
malaria. Clinical Biochemistry 28, 163–169.
Freeman, B.A., Crapo, J.D., 1982. Biology of dis-
ease: free radicals and tissue injury. Labora-
tory Investigation 47, 412–426.
Frei, B., England, L., Ames, B.N., 1989. Ascorbic
acid is an outstanding antioxidant in human
blood plasma. Proceedings of the National
Academy of Sciences 6, 6377- 6381.
Galle, J., 2001. Oxidative stress in chronic renal
failure. Nephrology Dialysis Transplantation
16, 2135-7.
Galle, J., Seibold, S., Wanner, C., 2003. Inflamma-
tion in uremic patients: what is the link?.
Kidney and Blood Pressure Research 26, 65-
75.
Giardini, O., Lubrano, R., Galluci, T., 1984. Effects
of alpha tocopherol administration on red
blood cell membrane lipid peroxidation in
haemodialysis patient. Clinical Nephrology
21, 174-177. 
Ginevri, F., Ghiggeri, G.M., Candiano, G., Oleg-
gini, R., Bertelli, R., Piccardo, M.T., Per-
fumo, F., Gusmano, R., 1989. Peroxidative
damage of the erythrocyte membrane in chil-
dren with nephrotic syndrome. Pediatric
Nephrology 3, 25–32.
Gorgum, M., Erdogan, D., Abban, G., Turkozkan,
N., Elbeg, S., 1999. Effects of vitamin E on
Adriamycin- induced nephrotoxicity at the
ultrastructural levels in guinea pigs. Nephron
82, 155-163. 
Green, D., Stone, N.J., Krumlovsky, F.A., 1983.
Putative atherogenic factors in patients with
chronic renal failure. Progress in Cardiovas-
cular Diseases 26, 133–144.
54
M.R. Abd Ellah / Journal of Advanced Veterinary Research 3 (2013) 52-56
Greene, E.L., Paller, M.S., 1991. Oxygen free rad-
icals in acute renal failure. Mineral and Elec-
trolyte Metabolism 17, 124- 132.
Halliwell, B., 1991. Reactive oxygen species in liv-
ing systems: Source biochemistry, role in
human disease. American Journal of Medi-
cine 91, 14–22
Halliwell, B., 1994. Free radicals antioxidants,
human disease: Curiosity cause or conse-
quence. Lancet 344, 721–724
Handelman, G.J., Walter, M.F., Adhikarla, R.,
Gross, J., Dallal, G.E., Levin, N. W., Blum-
berg, J.B., 2001. Elevated plasma F2-iso-
prostanes in patients on long-term
hemodialysis. Kidney International 59,
1960–1966.
Kikuchi, Y., Koyama, T., Koyama, Y., Trozawa, S.,
Arai, T., Hori-Moto, M., Kakiuchi, Y., 1982.
Red blood cell deformability in renal failure.
Nephron 30, 8–14.
Kitamura, M., Ishikawa, Y., 1999. Oxidant-induced
apoptosis of glomerular cells: intracellular
signaling and its intervention by
bioflavonoid. Kidney International 56, 1223–
1229.
Klahr, S., 2001. Urinary tract obstruction. Seminars
in Nephrology 21, 133–145.
Lee, J.I., Son, H.Y., Kim, M.C., 2006. Attenuation
of ischemia-reperfusion injury by ascorbic
acid in the canine renal transplantation. Jour-
nal of Veterinary Science 7, 375–379.
Maggi, E., Belazzi, R., Falaschi, F., Frattoni, A.,
Perani, G., Finardi, G., Gazo, A., Nai, M.,
Romanini, D., Bellono, G., 1994 Enhanced
LDL oxidation in uremic patients: an addi-
tional mechanism for accelerated atheroscle-
rosis?. Kidney International 45, 867-883.
Mantle, D., Preedy, V.R., 1999. Free radicals as
mediators of alcohol toxicity. Adverse Drug
React. Toxicological Reviews 18, 235–252.
Mark, S.P., John, R.H., Thomas, F.F., 1984. Oxy-
gen free radicals in ischaemic acute ranel
failure in the rat. Journal of Clinical Investi-
gations 74, 1156 - 1164.
Morosetti, M.E., Tozzo, C., Strolighi, L., Casciani,
C.U., 1987. Red blood cell lipid peroxidation
in hemodialysis chronic renal failure. Clini-
cal Nephrology 27, 238–241.
Paller, M.S., Hedlund, B.E., 1988. Role of iron in
postischemic renal injury in the rat. Kidney
International  34, 474 – 480
Paller, M.S., Weber, K., Patten, M., 1998. Nitric
oxide-mediated renal epithelial cell injury
during hypoxia and reoxygenation. Renal
Failure 20, 459–469.
Pár, A., Jávor, T., 1984. Alternatives in hepatopro-
tection: cytoprotection- influences on mono-
oxidase system-free radical scavengers a
review). Acta Physiologica Hungarica 64,
409–423.
Rao Srinivasa, P.V.L.N., Dakshinamurti, K.V.,
Saibaba, K.S.S. Vijayabhaskar, M., 1996. Ev-
idence for oxidant injury in patients with
postdiarrhoeal acute renal failure. Indian
Journal of Clinical Biochemistry 11, 66 - 69.
Ratych, R.E., Bulkley, G.B., 1986. Free radical me-
diated postischaemic reperfusion injury in
the kidney. Journal of Free Radical Biology
and Medicine 2, 311 - 319.
Sakatsume, M., Kadomura, M., Sakata, I., Imai, N.,
Kondo, D., Osawa, Y., Shimada, H., Ueno,
M., Miida, T., Nishi, S., Arakawa, M., Gejyo,
F., 2001. Novel glomerular lipoprotein de-
posits associated with apolipoprotein E2 ho-
mozygosity. Kidney International 59,
1911–1918.
Schiavon, R., Guidi, G.C., Biasioli, S., De Fanti,
E., Targa, L., 1994. Plasma glutathione per-
oxidase activity as an index of renal function.
European Journal of Clinical Chemistry and
Biochemistry 32, 759–765. 
Shah, S.V., 2001. Role of iron in progressive renal
disease. American Journal of Kidney Dis-
eases 37 (Suppl. 2), S30–S33.
Somani, S.M., Husain, K., Whitworth, C., Tram-
mell, G.L., Malafa, M., Rybak, L.P., 2000.
Dose-dependent protection by lipoicacid
against cisplatin-induced nephrotoxicity in
rats: antioxidant defense system. Pharmacol-
ogy and Toxicology 86, 234-241.
Stohs, S.J., 1995. The role of free radicals in toxi-
city and disease. Journal of Basic Clinical
Physiology and Pharmacology 6, 205–228.
Taccone-Gallucci, M., Lubrano, R., Meloni, C.,
Morosetti, M., Manca di Villahermosa, S.,
Scoppi, P., Palombo, G., Castello, M., Cas-
ciani, C., 1999. Red blood cell membrane
lipid peroxidation and resistance to erythro-
poietin therapy in hemodialysis patients.
Clinical Nephrology 52, 239-45.
Tappel, A.L., 1968. Will antioxidant nutrients slow
aging processes. Geriatrics 23, 97–105.
55
M.R. Abd Ellah / Journal of Advanced Veterinary Research 3 (2013) 52-56
Toborek, M., Wasik, T., Drozdz, M., Klin, M.,
Magner-Wrobel, K., Kopieczna-Grzebieniak,
E., 1992. Effect of hemodialysis on lipid per-
oxidation and antioxidant system in patients
with chronic renal failure. Metabolism 41,
1229–1232.
Trachtman, H., Chan, J.C., Chan, W., Valderrama,
E., Brandt, R., Wakely, P., Futterweit, S.,
Maesaka, J., Ma, C., 1996. Vitamin E ame-
liorates renal injury in an experimental model
of immunoglobulin a nephropathy. Pediatric
Research 40, 620–626.
Vamvakas, S., Bahner, U., Heidland, A., 1998.
Cancer in end-stage renaldisease: potential
factors involved. American Journal of
Nephrology 18, 89-95.
Vanholder, R., Sever, M.S., Erek, E., Lamiere, N.,
2000. Rhabdomyolysis. Journal of the Amer-
ican Society of Nephrology 11, 1553–1561
Wanner, C., Greiber, S., Krämer-Guth, A., Hein-
loth, A., Galle, J., 1997. Lipids and progres-
sion of renal disease: role of modified low
density lipoprotein and lipoprotein(a). Kid-
ney International 52 (Suppl. 63), S102–S106.
Wardle, E.N., 2005. Cellular oxidative process in
relation to renal disease. American Journal of
Nephrology 25, 13 -22. 
Wojcicka, G., Beltowski, J., 2001. Oxidative stress
in glomerulonephri- tis. Postepy higieny me-
dycyny doswiadczalnej 55, 855–869.
Yalcin, A.S., Yurtkuran, M., Dilek, K., Kilinc, A.,
Taga, Y., Emerk, K., 1989. The effect of vi-
tamin E therapy on plasma and erythrocyte
lipid peroxidation in chronic hemodialysis
patients. Clinical Chimistry Acta 185,109–
112.
Yawata, Y., Jacob, H., 1975. Abnormal red cell me-
tabolism in patients with chronic uremia: Na-
ture of the defect and its persistence despite
adequate hemodialysis. Blood 45, 231–239.
56
M.R. Abd Ellah / Journal of Advanced Veterinary Research 3 (2013) 52-56
